Literature DB >> 10074901

Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.

O Bögler1, M Nagane, J Gillis, H J Huang, W K Cavenee.   

Abstract

The early incidence of p53 mutation in astrocytomas suggests that it plays an important role in astrocyte transformation. Astrocytes isolated from homozygous p53 knockout mice grow rapidly, lack contact inhibition, and are immortal. Here we tested whether the loss of p53 is sufficient for progression to tumorigenicity of astrocytes. We grew primary astrocytes under three conditions for over 120 population doublings and assessed their antigenic phenotype, chromosome number, and expression of glioma-associated genes as well as their ability to form colonies in soft agarose and tumors s.c. and intracranially in nude mice. Under two conditions (10% FCS and 0.5% FCS plus 20 ng/ml EGF), cells acquired the ability to form colonies in soft agarose and tumors in nude mice, and this was accompanied by the expression of genes, including epidermal growth factor receptor, platelet-derived growth factor receptor alpha and beta, protein kinase Cdelta, and vascular endothelial growth factor, which are known to be aberrantly regulated in human astrocytomas. Under the third condition (0.5% FCS plus 10 ng/ml basic fibroblast growth factor), astrocytes gained the ability to form colonies in soft agarose and had abnormal chromosome numbers similar to cells in the first two conditions but did not form tumors in nude mice or overexpress glioma-associated genes. These data provide experimental evidence for the idea that the malignant progression initiated by the loss of p53 may be subject to modulation by extracellular environmental influences.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074901

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  7 in total

1.  P53 is required for the developmental restriction in Müller glial proliferation in mouse retina.

Authors:  Yumi Ueki; Mike O Karl; Samuel Sudar; Julia Pollak; Russell J Taylor; Kati Loeffler; Matthew S Wilken; Sara Reardon; Thomas A Reh
Journal:  Glia       Date:  2012-07-06       Impact factor: 7.452

Review 2.  The interface between glial progenitors and gliomas.

Authors:  Peter Canoll; James E Goldman
Journal:  Acta Neuropathol       Date:  2008-09-11       Impact factor: 17.088

3.  TWIST is expressed in human gliomas and promotes invasion.

Authors:  Maria C Elias; Kathleen R Tozer; John R Silber; Svetlana Mikheeva; Mei Deng; Richard S Morrison; Thomas C Manning; Daniel L Silbergeld; Carlotta A Glackin; Thomas A Reh; Robert C Rostomily
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

4.  Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males.

Authors:  Tao Sun; Nicole M Warrington; Jingqin Luo; Michael D Brooks; Sonika Dahiya; Steven C Snyder; Rajarshi Sengupta; Joshua B Rubin
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

5.  Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation.

Authors:  Christelle Dufour; Josette Cadusseau; Pascale Varlet; Anne-Laure Surena; Giselle P de Faria; Amelie Dias-Morais; Nathalie Auger; Nadine Léonard; Estelle Daudigeos; Carmela Dantas-Barbosa; Jacques Grill; Vladimir Lazar; Philippe Dessen; Gilles Vassal; Vincent Prevot; Ariane Sharif; Herve Chneiweiss; Marie-Pierre Junier
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

6.  Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival.

Authors:  Stacey L Thomas; Chad R Schultz; Ezekiell Mouzon; William A Golembieski; Reima El Naili; Archanna Radakrishnan; Nancy Lemke; Laila M Poisson; Jorge A Gutiérrez; Sandra Cottingham; Sandra A Rempel
Journal:  Brain Pathol       Date:  2015-04-20       Impact factor: 6.508

7.  Akt and c-Myc induce stem-cell markers in mature primary p53⁻/⁻ astrocytes and render these cells gliomagenic in the brain of immunocompetent mice.

Authors:  Josefine Radke; Ginette Bortolussi; Axel Pagenstecher
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.